With proper background knowledge, there are other ways to obtain genetic information about oneself than through genetic testing, e.g., through family history, but in this text we will confine to genetic information obtained through DNA-analysis.
2.
TakalaT., Genes, Sense and Sensibility: Philosophical Studies on the Ethics of Modern Biotechnologies (Helsinki: Reports from the Department of Philosophy, University of Turku, 2000): at 94–100.
3.
HerringJ.FosterC.,‘Please Dont Tell Me: The Right Not to Know, Cambridge Quarterly of Healthcare Ethics21, no. 1 (2012): 20–29, at 22–24.
4.
TakalaT., Genetic Ignorance and Reasonable Paternalism, Theoretical Medicine and Bioethics22, no. 5 (2001): 485–491, at 487.
5.
LaurieG. T., In Defence of Ignorance: Genetic Information and the Right Not to Know, European Journal of Health Law6, no. 2 (1999): 119–132, at 122.
6.
ChadwickR., The Philosophy of the Right to Know and the Right Not to Know, in ChadwickR.LevittM., and ShickleD., eds., The Right to Know and the Right Not to Know (Aldershot: Ashgate Publishing Company, 1997): 13–22, at 18.
7.
The interest individuals have in their genetic privacy is developed and forcefully defended in LaurieG. T., Genetic Privacy: A Challenge to Medico-Legal Norms, (Cambridge: Cambridge University Press, 2002): Passim.
8.
This is the group of people that clinical geneticists are interested in when constructing a family tree or pedigree of the index-person; see HarperP. S., Practical Genetic Counselling, 7th edition (London: Hodder Arnold, 2010): at 5–8.
9.
ThorogoodA.KnoppersB. M.DondorpW. J., and de WertG. M. W. R., Whole-Genome Sequencing and the Physician, Clinical Genetics81, no. 6 (2012): 511–513.
10.
For an overview, see MariettaC.McGuireA. L., Currents in Contemporary Ethics: Direct-to-Consumer Genetic Testing: Is It the Practice of Medicine?Journal of Law, Medicine & Ethics37, no. 2 (2009): 369–374.
11.
KaganS., The Limits of Morality (New York: Oxford University Press, 1989): at 219–226. In the discussion of rights to genetic information, Hohfelds concept of claim-rights, which include both options and injunctions, are often presupposed (see HäayryM.TakalaT., Genetic Information, Rights, and Autonomy, Theoretical Medicine and Bioethics22, no. 5 (2001): 403–414, at 404 RhodesR., Genetic Links, Family Ties and Social Bonds: Rights and Responsibilities in the Face of Genetic Knowledge, Journal of Medicine and Philosophy23, no. 1 (1998): 10–30, at 15. So, terminology sometimes differs; for example, options are sometimes called licences; see HäayryTakala, id., at 404).
12.
See Kagan, supra note 11.
13.
Rather, if anything, it is explicitly denied; see, for example, Rhodes, supra note 11, at 26.
14.
HarrisJ.KeywoodK., Ignorance, Information, and Autonomy, Theoretical Medicine and Bioethics22, no. 5 (2001): 415–436.
15.
OstD. E., The ‘Right Not to Know, Journal of Medicine and Philosophy9, no. 3 (1984): 301–312; Rhodes, supra note 11.
16.
See Rhodes, supra note 11, at 12–14.
17.
TakalaT.HäayryM., Genetic Ignorance, Moral Obligations and Social Duties, Journal of Medicine and Philosophy25, no. 1 (2000): 107–113, at 109.
18.
Id., at 111.
19.
As claimed, for instance, by Ost, supra note 15.
20.
See Rhodes, supra note 11, at 13–14.
21.
An exclusion test, selecting against the fourth chromosomes of the affected grandparent, can also be used if it is known which grandparent that is a carrier
22.
see AsscherE.KoopsB. J., The Right Not to Know and Preimplantation Genetic Diagnosis for Huntingtons Disease, Journal of Medical Ethics36, no. 1 (2010): 30–33. For instance, Dutch law requires that prospective parents that want PGD for Huntingtons test themselves first; see AsscherKoops, supra note 21.
23.
I am here presupposing the premise that if one makes an abortion or discards an embryo, the very same child cannot in fact be born through later pregnancy or grow from another embryo. Although not self-evident, this assumption should be uncontroversial (especially regarding abortion) see ParfitD., Reasons and Persons (Oxford: Oxford University Press, 1984): at 351–356.
24.
For a recent discussion and further references, see HopeT.McMillanJ., Physicians Duties and the Non-Identity Problem, American Journal of Bioethics12, no. 8 (2012): 21–29.
25.
See TakalaHäayry, supra note 17, at 109. Supposedly, Harriette and her husband have reasons to suspect that they are carriers of the gene to start with.
26.
Similar examples in this regard would be Lesch-Nyhan and Krabbes disease; see MuntheC., Pure Selection: The Ethics of Preimplantation Genetic Diagnosis and Choosing Children without Abortion (Gothenburg: Acta Universitatis Gothoburgensis, 1999): at 97.
27.
What one should say is thus not that it is better for the child not to exist, but that it is better, on the whole, if the child never exists, and if the child is brought into existence, the child is harmed.
28.
Even though the risk to contract a disease at some point in life due to a single gene disorder is 2–4%, very few of these diseases can unambiguously be claimed to make the affected persons life not worth living, and there is seldom initial suspicion that would make it an alternative for the parents to seek the genetic information in question; see Munthe, supra note 26.
29.
ParkerM.LucassenA., Concern for Families and Individuals in Clinical Genetics, Journal of Medical Ethics29, no. 2 (2003): 70–73, at 73.
30.
For a more thorough argument in favour of these being the only two final or intrinsic values that can be realized for both the index-person and his relatives, see JuthN., Genetic Information – Values and Rights: The Morality of Presymptomatic Genetic Testing (Saarbrüucken: Lambert Academic Publishing, 2012): at Chapter II.
31.
AdelswüardV.SachsL., Framtida skuggor: Samtal om risk, prevention och den genetiska familjen (Future Shadows: Conversations on Risk, Prevention and the Genetic Family) (Lund: Arkiv föorlag, 2002): at 83ClarkeA., Commentary to: HallowellN., Balancing Autonomy and Responsibility: The Ethics of Generating and Disclosing Genetic Information, Journal of Medical Ethics29, no. 2 (2003): 74–83, at 80.
32.
Although there may be psychological advantages for relatives, e.g., strengthened emotional bonds within family and time for psychological adjustment to cope with the (more or less probable) disease; see Juth, supra note 30, at 54–55.
33.
This strategy is implemented in, for instance, the UK and Sweden.
34.
Some empirical findings seem to support this, for instance, see HallowellN., supra note 31, at 75–77. They interviewed women who were diagnosed with breast and ovarian cancer and who tested for BRCA1/2. A large majority of these women stated that their primary motive for testing was the good of their relatives in some way or another, e.g., in terms of their autonomy and/or well-being.
35.
KnoppersB. M., Genetic Information and the Family: Are We Our Brothers Keeper?Trends in Biotechnology20, no. 2 (2002): 85–86, at 85.
36.
BeauchampT. L.ChildressJ. F., Principles of Biomedical Ethics, 5th ed. (New York: Oxford University Press, 2001): at 304–305.
37.
There seems to be some indication that they are, perhaps partly because they often also have the role of the researcher interested in collecting data; see AdelswüardSachs, supra note 31, at 84–86.
38.
See Knoppers, supra note 35, at 86.
39.
That is, the so called therapeutic gap remains; see Juth, supra note 30, at 7 and section I.4.
40.
See Juth, supra note 30, at 53, 70–71, and 78–79.
41.
Although this can be questioned as well, not least since the treatment of prophylactic mastectomy is burdensome in itself; see Juth, supra note 30, at 52. This shows that further conditions should be added: that the prevention or treatment available must be sufficiently efficient and not too burdensome.
42.
DoukasD. J.BergJ. W.The Family Covenant and Genetic Testing, American Journal of Bioethics1, no. 3 (2001): 2–10.
43.
See ParkerLucassen, supra note 29, at 72.
44.
See Clarke, supra note 31, at 81.
45.
It has even entered standard text books on medical ethics; see HopeT., Medical Ethics: A Very Short Introduction (Oxford: Oxford University Press, 2004): at 97–98.
46.
ParkerM.LucassenA., Genetic Information: A Joint Account?BMJ329, no. 7458 (2004): 165–167, at 166.
47.
See, for example, ParkerLucassen, supra note 46, at 166; Knoppers, supra note 35, at 86.
48.
The argument has also been called the genetic information is familial thesis; see LiaoS. M., Is There a Duty to Share Genetic Information?Journal of Medical Ethics35, no. 5 (2009): 306–309, at 306.
49.
See, for instance, HolmS., There Is Nothing Special about Genetic Information, in ThompsonA.ChadwickR., eds., Genetic Information: Acquisition, Access and Control (New York: Kluwer Academics/Plenum Publishers, 1999): at 97–103 49.Juth, supra note 30, at 373–374. Of course, when enough is at stake, we do think that considerations of confidentiality are outweighed by the interests of others when it comes to sharing information about contagious diseases with others who may find it informative, but this is far from saying that it should be a default.
50.
See Rhodes, supra note 11, at 25.
51.
Id., at 24. One can discuss whether this is disclosing genetic information, but one could easily change the case so that it is obviously about disclosure.
52.
Id.
53.
Rhodes concurs with this when discussing what reasons we normally present for having certain responsibilities; id., at 21.